A new group of antibiotics that may provide relief to people affected by antibiotic resistance, has been developed by a team of researchers from Virginia Institute of Technology. These new antibiotics can successfully target the bacteria Staphylococcus aureus (staph) and the antibiotic-resistant strains commonly known as methicillin-resistant Staphylococcus aureus (MRSA). The paper was published in Medicinal Chemistry Communications.